Concourse Financial Group Securities, Inc. Cytokinetics Inc Transaction History
Concourse Financial Group Securities, Inc.
- $1.56 Billion
- Q2 2024
A detailed history of Concourse Financial Group Securities, Inc. transactions in Cytokinetics Inc stock. As of the latest transaction made, Concourse Financial Group Securities, Inc. holds 1 shares of CYTK stock, worth $55. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1
Previous 1
-0.0%
Holding current value
$55
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
21 transactions
Others Institutions Holding CYTK
# of Institutions
406Shares Held
126MCall Options Held
3.29MPut Options Held
2.01M-
Black Rock Inc. New York, NY14.7MShares$816 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.4MShares$636 Million0.01% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD8.14MShares$453 Million0.28% of portfolio
-
Wellington Management Group LLP Boston, MA7.51MShares$418 Million0.07% of portfolio
-
State Street Corp Boston, MA6.55MShares$364 Million0.02% of portfolio
About CYTOKINETICS INC
- Ticker CYTK
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 94,144,096
- Market Cap $5.23B
- Description
- Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...